News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MILANO VINCENT
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| MILANO VINCENT (Director) has filed a Form 4 on Aceragen, Inc.|
Txns:
| Sold 3,283 shares
@ $0.5331, valued at
$1.8k
|
|
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/05/2023 |
4
| MILANO VINCENT (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 15,750 options to buy
@ $8.7, valued at
$137k
Granted 4,660 restricted stock units
@ $0
Exercised 4,507 restricted stock units
@ $0 |
|
| 06/02/2023 |
4
| MILANO VINCENT (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 680 shares
@ $8.27, valued at
$5.6k
|
|
| 03/02/2023 |
4
| MILANO VINCENT (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 635 shares
@ $8.85, valued at
$5.6k
|
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2022 |
4
| MILANO VINCENT (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 404 shares
@ $13.9, valued at
$5.6k
|
|
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| MILANO VINCENT (PRESIDENT AND CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 99,000 options to buy
@ $0.535, valued at
$53k
|
|
| 01/26/2022 |
4
| MILANO VINCENT (PRESIDENT AND CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 25,000 options to buy
@ $0.5746, valued at
$14.4k
|
|
| 11/24/2021 |
4
| MILANO VINCENT (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Bought 7,500 shares
@ $12.19, valued at
$91.4k
|
|
| 07/28/2021 |
4
| MILANO VINCENT (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 66,667 options to buy
@ $17.25, valued at
$1.2M
|
|
| 07/28/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/12/2021 |
4
| MILANO VINCENT (PRESIDENT AND CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 124,000 options to buy
@ $1.11, valued at
$137.6k
|
|
| 06/04/2021 |
4
| MILANO VINCENT (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 12,250 options to buy
@ $21.9, valued at
$268.3k
Granted 3,356 restricted stock units
@ $0 |
|
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| MILANO VINCENT (President & CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 128,170 shares
@ $0
Sold 37,169 shares
@ $4.3188, valued at
$160.5k
|
|
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| MILANO VINCENT (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.41, valued at
$23.3k
|
|
| 01/14/2020 |
4
| MILANO VINCENT (President & CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 37,000 shares
@ $0
Granted 92,000 options to buy
@ $1.79, valued at
$164.7k
|
|
| 01/14/2020 |
4/A
| MILANO VINCENT (President & CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Sold 3,006 shares
@ $1.7804, valued at
$5.4k
|
|
| 01/10/2020 |
4
| MILANO VINCENT (President & CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Sold 3,006 shares
@ $1.7804, valued at
$5.4k
|
|
| 01/09/2020 |
4
| MILANO VINCENT (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $1.85, valued at
$40.7k
|
|
| 01/09/2020 |
3
| MILANO VINCENT (Director) has filed a Form 3 on Aclaris Therapeutics, Inc. |
| 12/17/2019 |
4
| MILANO VINCENT (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Unknown transaction of 3,000 shares
@ $114.5, valued at
$343.5k
Disposed/sold 4,000 options to buy
@ $81.53, valued at
$326.1k
Disposed/sold 4,000 options to buy
@ $50.93, valued at
$203.7k
Disposed/sold 6,000 options to buy
@ $56.22, valued at
$337.3k
Disposed/sold 37,203 options to buy
@ $3.45, valued at
$128.4k
|
|
| 07/11/2019 |
4
| MILANO VINCENT (President & CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 84,500 options to buy
@ $2.52, valued at
$212.9k
|
|
| 06/03/2019 |
4
| MILANO VINCENT (Director) has filed a Form 4 on Spark Therapeutics, Inc.|
Txns:
| Exercised 1,500 restricted stock units
@ $0 |
|
| 01/07/2019 |
4
| MILANO VINCENT (President & CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 33,750 shares
@ $0
Granted 84,500 options to buy
@ $3.14, valued at
$265.3k
|
|
| 12/26/2018 |
4
| MILANO VINCENT (President & CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Bought 15,000 shares
@ $2.9282, valued at
$43.9k
|
|
| 08/15/2018 |
4
| MILANO VINCENT (President & CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 65,000 options
@ $7.39, valued at
$480.4k
|
|
| 08/08/2018 |
4
| MILANO VINCENT (President & CEO) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Bought 10,000 shares
@ $5.51, valued at
$55.1k
|
|
|
|
|